Skip to content
Latest News
Chembio Diagnostics (CEMI) Stock Surges After Receiving $28.3m Order From Bio-Manguinhos

Chembio Diagnostics (NASDAQ: CEMI) stock is surging premarket on Wednesday after receiving a $28.3 million purchase order from Bio-Manguinhos to purchase Chembio’s DPP SARS-CoV-2 Antigen tests. The tests are to be delivered during this year to sup

Sam Boughedda
Velocys Share Price Edges Higher After Extending BA Altalto Option Agreement

Sustainable fuels technology company Velocys plc (LON: VLS) and British Airways have agreed to extend the current option agreement for the Altalto project by one year to 31st March 2022. Velocys shares have gained 3.83% following the news, priced

Sam Boughedda
Petra Diamonds (PDL) Shares Rally As Revenue Surges

Petra Diamonds (LON: PDL) shares are rallying on Wednesday after the company revealed its revenue rose in FY 2021, with expectations for higher production in 2022. Revenue increased 38% to $406.9 million in 2021, compared to $295.8 million in 2020

Sam Boughedda
Supply@ME Capital (SYME) Shares Fell 12.8% After Delaying Full-Year 2020 Results

Shares of inventory monetisation company Supply@Me Capital PLC fell 12.8% after announcing plans to delay the release of its full-year 2020 financial results to May. The company said that the delay was due to challenges in remotely preparing and a

Simon Mugo
Sareum Shares Edge 9.6% Higher on Upbeat Half-Year Results and Operations Update

Shares of Sareum Holdings Plc (LON: SAR) edged 9.61% higher after announcing the preliminary results for the six months ended 31 December 2020. The biotech company made a loss of £550,000 during the period showing an improvement from the £610,000

Simon Mugo
Arena Events Group (ARE) Agrees To Repay Short-Term Financing Facility

Arena Events Group (LON: ARE) announced on Wednesday that it has agreed with Lombard Odier Investment Management (LOIM) to repay and cancel the short-term financing facility. LOIM, a significant shareholder in Arena Events Group, provided the shor

Sam Boughedda
Mosman Oil and Gas (MSMN) Completes EP-145 Airborne Survey, Shares Down

Mosman Oil and Gas (LON: MSMN) shares are down on Wednesday after confirming that it has completed the airborne gravity and gradiometry data acquisition over permit EP-145 located in the Amadeus Basin in Central Australia. The company described th

Sam Boughedda
Union Jack Oil (UJO) Shares Edge Higher On West Newton B-1Z Update

Shares of Union Jack Oil (LON: UJO) are edging higher on Wednesday after the company provided an update on the ongoing testing of the West Newton B-1Z well located within the Western Sector of the Southern Permian Basin, North of the River Humber, UK

Sam Boughedda
Open Orphan Shares Have Fallen 53.2% From Their April Highs. Have They Bottomed?

Shares of Open Orphan PLC (LON: ORPH) have fallen 53.2% from their April highs as investors factor in the demerger of its drug development business and the loss of potential future revenues. The biotech company created a new entity known as Poolbe

Simon Mugo
Fevertree Shares Plunged 9.73% on H1 2021 Results as Revenues Surge, Margins Shrink

Shares of Fevertree Drinks PLC (LON: FEVR) plunged 9.73% after revealing that its margins were under pressure amid rising raw material and production costs. The spirits maker released its financial results for the first half of 2021, where its rev

Simon Mugo
Ocado Shares Plunge 4.74% Amid Piling Order Cancellations as the UK Reopens

Shares of Ocado Group PLC (LON: OCDO) fell 4.74% after a fire at one of its warehouses caused by the collision of three robots forced the company to cancel thousands of customer orders as the warehouses remained closed on Monday. The company, whic

Simon Mugo
AstraZeneca Shares Pulled Back Despite China Approving Its Lung Cancer Drug, Here’s Why

Shares of AstraZeneca plc (LON: AZN) fell despite China approving its extensive-stage small cell lung cancer (ES-SCLC) treatment following a successful phase III trial, showing that it was more effective than chemotherapy. The drug showed that it

Simon Mugo
ARC Minerals Shares Edged 2.61% Higher After Starting Zambian Drill Programme

Shares of ARC Minerals Ltd (LON: ARCM) edged 2.61% higher after starting a diamond drilling programme at some of its Zambian license areas. After analysing last year’s exploration drilling programme results, the company started drilling at the Fwi

Simon Mugo
Futura Medical (FUM) Shares Fall Despite the FDA Approving Its Human Factors Study

Shares of Futura Medical plc. (LON: FUM) were trading lower today despite announcing that the US Food and Drug Administration (FDA) had approved its design for a human factors study to determine whether med can correctly self-diagnose erectile dysfun

Simon Mugo
Power Metal Resources (POW) Shares Gain On Canadian Lithium Earn-In Agreement

Power Metal Resources (LON: POW) shares are rising on Friday after the company said its Canadian subsidiary, Power Metal Resources Canada, has signed an earn-in agreement to potentially acquire a 100% interest in two Canadian lithium pegmatite explor

Sam Boughedda
Creo Medical Shares Fall After Announcement Of US HQ

Creo Medical Group's (LON: CREO) shares are down on Friday following the announcement that it has opened its United States headquarters at the Summit, Danbury, Connecticut, USA. The AIM-listed medical device firm said the space is designed to supp

Sam Boughedda
Micro Focus (MCRO) Settles Wapp Tech Patent Dispute

Micro Focus International (LON: MCRO, NYSE: MFGP) said on Friday that it has now reached a settlement with Wapp regarding their claim against the company. At the start of July, Micro Focus announced that Wapp brought a claim against them, arguing

Sam Boughedda
AIG Stock Climbs After Selling Stake in Life & Retirement Business To Blackstone

American International Group (NYSE: AIG), a global insurance firm, yesterday announced that it is selling a 9.9% stake in its Life & Retirement Business to Blackstone for $2.2 billion. As part of the agreement, AIG also entered into a long-ter

Sam Boughedda
NLS Pharmaceutics (NLSP) Stock Surges After FDA Accepts IND Application

Shares of NLS Pharmaceutics (NASDAQ: NLSP) are rallying premarket after the company announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug application (IND) for Quilience. Quilience is the company‘s lead

Sam Boughedda
Experian (EXPN) Shares Gain Following Revenue Growth

Experian (LSE: EXPN), a global information services company, issued an update on its trading performance on Thursday morning, resulting in a rise in its share price. The company's CEO, Brian Cassin, revealed they "now expect total revenue growth f

Sam Boughedda